Cancer BiologybioRxivPreprint
Context-dependent triggering of STING-interferon signaling by CD11b agonists supports anti-tumor immunity in mouse models and human cancer patients
X. Liu, G. D. Hogg, c. zuo…·D. DeNardo
This study identifies how CD11b agonists trigger STING-interferon signaling in tumor-associated macrophages to enhance anti-tumor immunity in mouse models and human cancer patients.
DOI 10.1101/2022.03.22.485233